1. Prick JJ, Gabreëls-Festen AA, Korten JJ, van der Wiel TW. Neurological manifestations of the hypereosinophilic syndrome (HES). Clin Neurol Neurosurg. 1988. 90:269–273.
2. Moore PM, Harley JB, Fauci AS. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med. 1985. 102:109–114.
3. Torvik A. The pathogenesis of watershed infarcts in the brain. Stroke. 1984. 15:221–223.
4. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975. 54:1–27.
5. Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest. 1993. 91:1721–1730.
6. Sarazin M, Caumes E, Cohen A, Amarenco P. Multiple microembolic borderzone brain infarctions and endomyocardial fibrosis in idiopathic hypereosinophilic syndrome and in Schistosoma mansoni infestation. J Neurol Neurosurg Psychiatry. 2004. 75:305–307.
7. Pollanen MS, Deck JH. The mechanism of embolic watershed infarction: experimental studies. Can J Neurol Sci. 1990. 17:395–398.
8. Slungaard A, Vercellotti GM, Walker G, Nelson RD, Jacob HS. Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med. 1990. 171:2025–2041.
9. McMillan HJ, Johnston DL, Doja A. Watershed infarction due to acute hypereosinophilia. Neurology. 2008. 70:80–82.
10. Koennecke HC, Bernarding J. Diffusion-weighted magnetic resonance imaging in two patients with polycythemia rubra vera and early ischemic stroke. Eur J Neurol. 2001. 8:273–277.